Skip to main content
Igor Laskowski, MD, Vascular Surgery, Valhalla, NY

IgorALaskowskiMD

Vascular Surgery Valhalla, NY

Attending Surgeon Chief, Section of Endovascular Surgery, Westchester Medical Center, Associate Professor of Surgery, New York Medical College

Dr. Laskowski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Laskowski's full profile

Already have an account?

  • Office

    100 Woods Rd
    Fl 1
    Valhalla, NY 10595
    Phone+1 914-909-6900
    Fax+1 914-493-2828

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Vascular Surgery - Independent, 2006 - 2007
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2001 - 2006
  • Harvard Medical School
    Harvard Medical SchoolPost-Doctoral Fellowship, 1998 - 2001
  • Medical University of Warsaw
    Medical University of WarsawClass of 1996

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2004 - 2026
  • American Board of Surgery Surgery
  • American Board of Surgery Vascular Surgery
  • ARDMSRPVI
  • ARDMSRVT

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Conolly, 2017
  • Regional Top Doctor Castle Connolly, 2014
  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Westchester Medical Center and BioGenCell Open BioGenCell's Fourth Chronic Limb-Threatening Ischemia Clinical Trial Site in the United States
    Westchester Medical Center and BioGenCell Open BioGenCell's Fourth Chronic Limb-Threatening Ischemia Clinical Trial Site in the United StatesSeptember 6th, 2023
  • WMC and BioGenCell Open Chronic Limb-Threatening Ischemia Trial Site
    WMC and BioGenCell Open Chronic Limb-Threatening Ischemia Trial SiteSeptember 8th, 2023

Professional Memberships

Other Languages

  • Polish